Profound Medical Corp.
PROF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27,816 | -$28,323 | -$28,669 | -$30,699 |
| Dep. & Amort. | $936 | $929 | $1,604 | $1,879 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,581 | $3,417 | $4,238 | $7,205 |
| Change in WC | $591 | $540 | -$5,629 | -$877 |
| Other Non-Cash | $255 | $828 | $2,656 | $132 |
| Operating Cash Flow | -$23,453 | -$22,609 | -$25,800 | -$22,360 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$32 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$561 |
| Investing Cash Flow | $0 | $0 | $0 | -$593 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,560 | -$912 | $6,917 | -$386 |
| Stock Issued | $62,106 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,850 | $2,668 | $114 | $6,334 |
| Financing Cash Flow | $54,696 | $1,756 | $7,031 | $5,948 |
| Forex Effect | -$2,544 | $549 | -$1,866 | $244 |
| Net Chg. in Cash | $28,699 | -$20,304 | -$20,635 | -$16,761 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,213 | $46,517 | $67,152 | $83,913 |
| End Cash | $54,912 | $26,213 | $46,517 | $67,152 |
| Free Cash Flow | -$23,453 | -$22,609 | -$25,800 | -$22,953 |